Topiramate 31722-0550
Product NDC
31722-0550- Manufacturer
- Camber Pharmaceuticals, Inc.
- Dosage Form
- Capsule, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- April 1, 2026
- Listing Expires
- December 31, 2027
- Application
- ANDA217443
Need to source Topiramate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Topiramate | 200 mg/1 |
Drug Class
Cytochrome P450 2C19 Inhibitors [MoA]Cytochrome P450 3A4 Inducers [MoA]Decreased Central Nervous System Disorganized Electrical Activity [PE]
Packaging Options(1)
30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (31722-550-30)